376382-11-5

376382-11-5 structure

Name: BRD-7389
Chemical Name: bas 05532738
CAS Number: 376382-11-5
Molecular Formula: C₂₄H₁₈N₂O₂
Molecular Weight: 366.41200
Catalog: Signaling Pathways MAPK/ERK Pathway Ribosomal S6 Kinase (RSK)
Create Date: 2016-07-01 07:04:20
Modify Date: 2026-07-01 13:31:39
BRD7389 is a specific RSK family kinase inhibitor with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively. BRD7389 is a small-molecule inducer of insulin expression in pancreatic α-cells[1].

Name	bas 05532738
Synonyms	BRD7389,cancer,S6K,Inhibitor,BRD 7389,colon,inhibit,RSK,islets,diabetes,BRD-7389,pancreatic,SNU-407,Ribosomal S6 Kinase (RSK) 1-(Phenethylamino)-2H-naphtho[1,2,3-de]quinoline-2,7(3H)-dione 1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione BRD-7389, p90 ribosomal S6 kinase RSK inhibitor BRD 7389 (BRD7389) 1-Phenethylamino-3H-naphtho[1,2,3-de]quinoline-2,7-dione 1-[(2-Phenylethyl)amino]-naphtho-3H-[1,2,3-de]quinoline-2,7-dione BRD7389, 10 mM in DMSO 3H-Naphtho[1,2,3-de]quinoline-2,7-dione, 1-[(2-phenylethyl)amino] Insulin Expression Inducer, BRD7389 - - Calbiochem BRD7389 >= (HPLC) hms1493i11 Insulin Expression Inducer, BRD7389

Description	BRD7389 is a specific RSK family kinase inhibitor with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively. BRD7389 is a small-molecule inducer of insulin expression in pancreatic α-cells[1].
Related Catalog	Research Areas >> Metabolic Disease Signaling Pathways >> MAPK/ERK Pathway >> Ribosomal S6 Kinase (RSK)
Target	RSK1:1.5 μM (IC50) RSK2:2.4 μM (IC50) RSK3:1.2 μM (IC50) CDK5/p35:6.5 μM (IC50) DRAK1:2.8 μM (IC50) FLT3:3.5 μM (IC50) PIM1:3.7 μM (IC50) PKG1α:6.5 μM (IC50) SGK:13.8 μM (IC50)
In Vitro	BRD7389 (0.425-6.8 μM) induces insulin expression in mouse α-cells after 3 days treatment. BRD7389 induces a dose-dependent up-regulation of insulin (Ins2) mRNA, peaking at 0.85 μM; 5 days treatment with BRD7389 results in greater induction of insulin gene expression, about 50-fold at 0.85 μM[1]. BRD7389 (0.85-6.8μM) significantly up-regulates Pdx1 mRNA expression in mouse α-cell line[1]. BRD7389 also increases β-cell-specific gene expression in primary human islet cells[1]. BRD7389 (1 μM; added 30 min prior to Carbachol treatment 48 h) fully abolishes carbachols timulated cell proliferation, but has little effect on the basal level of proliferation[2]. RT-PCR[1] Cell Line: Mouse α-cell line Concentration: 0.425, 0.85, 1.7, 3.4, 6.8 μM Incubation Time: 3 days and 5 days Result: Up-regulated expression of Pdx1. Cell Proliferation Assay[2] Cell Line: SNU-407 colon cancer cell Concentration: 1 μM Incubation Time: Added 30 min prior to Carbachol treatment (48 h) Result: Almost completely blocked Carbachol (1 mM)-stimulated cell proliferation.
References	[1]. Fomina-Yadlin D, et al. Small-molecule inducers of insulin expression in pancreatic alpha-cells. Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15099-104. [2]. Park YS, et al. EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors. Mol Cell Biochem. 2012 Nov;370(1-2):191-8.

Molecular Formula	C₂₄H₁₈N₂O₂
Molecular Weight	366.41200
Exact Mass	366.13700
PSA	62.22000
LogP	4.87940

Hazard Statements	H413
RIDADR	NONH for all modes of transport

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1141474-06-7	1702730-79-7
1219970-04-3	1268263-22-4
2200690-34-0	1240137-37-4
1251034-72-6	1334366-82-3
1449668-91-0	1301204-93-2